Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
Obstructive airway diseases, e.g., chronic obstructive pulmonary disease (COPD) and asthma, represent leading causes of morbidity and mortality worldwide. However, the efficacy of currently available inhaled therapeutics is not sufficient for arresting disease progression and decreasing mortality, h...
Main Authors: | You Xu, Aneesh Thakur, Yibang Zhang, Camilla Foged |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/2/177 |
Similar Items
-
Recent advances in capsule-based dry powder inhaler technology
by: Federico Lavorini, et al.
Published: (2017-05-01) -
Adequacy of inhaler technique used by people with asthma or chronic obstructive pulmonary disease
by: Bang C, et al.
Published: (2013-09-01) -
Dispensing Guideline of Dry Powder Inhaler for Asthmatic and Chronic Obstructive Pulmonary Disease Patients at Out-Patient Dispensing Department
by: Karnchanok Maliphan, et al.
Published: (2012-10-01) -
An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease
by: Seçil Çakmaklı, M.D., et al.
Published: (2023-08-01) -
Evaluation of Inhaler Technique in Patients with Asthma and Chronic Obstructive Pulmonary Disease in Andaman and Nicobar Islands – An Observational Study
by: M. Natraj, et al.
Published: (2025-01-01)